
Opinion|Videos|August 16, 2024
ACIP Recommendations for Pneumococcal Vaccination
The panel of experts examines the most recent ACIP recommendations for pneumococcal vaccination in adults aged 65 and older, highlighting key updates and changes to the guidelines.
Advertisement
Episodes in this series

What do the updated ACIP recommendations suggest for pneumococcal vaccination in adults aged 65 and older? High-risk adults aged 19-64?
- Patients can receive PCV20 if they have already received PCV13 (at any age) and PPSV23 (at or after the age of 65 years old). What is the significance of receiving PCV20 after receiving PCV13 AND PPSV23?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5




















































































































































































































